Forte Biosciences Inc reports results for the quarter ended in December - Earnings Summary

Forte Biosciences

01/04/2022 14:20

* Forte Biosciences Inc  FBRX.OQ  reported a quarterly
adjusted
loss of 21 cents​​ per share for the quarter ended in December.
The mean expectation of three analysts for the quarter was for a
loss of 32 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Forte Biosciences Inc's reported EPS for the quarter was a
loss
of 21 cents​.
    * The mean earnings estimate of analysts had risen by
about 5.9%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Forte Biosciences Inc shares had held steady so far this
quarter and lost 31.8% so far this year.
    * The company reported a quarterly loss of $3.34 million.
    * Wall Street's median 12-month price target for Forte
Biosciences
Inc is $3.50 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated April 1 at 01:19 p.m.  ​All
figures in US dollars unless otherwise stated